Wall Street analyst estimates for Solana Company (HSDT): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
Solana Co. is a medical device firm specializing in neurotechnology, dedicated to improving neurological wellness. The company's strategy involves developing, licensing, and acquiring innovative, non-invasive platform technologies. These technologies are designed to enhance the brain's intrinsic capacity for self-healing and mitigate the effects of neurological diseases or trauma.
Analyst Consensus
| Strong Buy | 0 |
| Buy | 3 |
| Hold | 2 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 5 |
| Avg rating (1-5) | 0.60 |
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2026-11-17 | $0.02 | ||
| 2026-08-14 | $-0.38 | $-0.02 | -1800.0% |
| 2026-05-15 | $-1.30 | $-0.12 | -983.3% |
| 2026-03-30 | $4.25 | $-26.50 | +116.0% |
| 2025-11-18 | $-32.89 | $-50.50 | +34.9% |
| 2025-08-15 | $-0.80 | $-1.28 | +38.0% |
| 2025-05-01 | $-3.82 | $-4.35 | +12.1% |
| 2025-03-26 | $-7.72 | $-7.05 | -9.5% |
Valuation Ratios
| Price / Book | 1.09 |
| EV / EBITDA | -0.97 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | $478000 | $1.5M | $661000 | $522000 | $787000 | $644000 | $520000 | $6.0M |
| Cost of Revenue | 0 | $17000 | $59000 | $910000 | $751000 | $298000 | $463000 | $583000 | $582000 | $500000 |
| Gross Profit | 0 | -$17000 | $419000 | $586000 | -$90000 | $224000 | $324000 | $61000 | -$62000 | $5.5M |
| Research & Development | $3.6M | $14.4M | $9.9M | $8.1M | $4.6M | $6.0M | $4.3M | $2.9M | $3.7M | $3.5M |
| Selling, General & Admin | $5.7M | $8.4M | $17.2M | $16.5M | $9.4M | $12.2M | $10.6M | $9.3M | $10.1M | $23.1M |
| Operating Expenses | $9.3M | $22.8M | $27.1M | $24.6M | $14.0M | $18.4M | $15.8M | $12.5M | $13.8M | $26.6M |
| Operating Income | -$9.3M | -$22.9M | -$26.7M | -$24.0M | -$14.1M | -$18.1M | -$15.5M | -$12.4M | -$13.9M | -$21.1M |
| EBITDA | -$6.8M | -$28.0M | -$28.6M | -$9.6M | -$13.6M | -$17.8M | -$14.5M | -$12.1M | -$13.8M | -$39.6M |
| Interest Expense | $46920 | 0 | 0 | 0 | 0 | 0 | $834000 | 0 | $17000 | $635000 |
| Pre-tax Income | -$6.9M | -$28.0M | -$28.6M | -$9.8M | -$14.1M | -$18.1M | -$14.1M | -$8.8M | -$11.7M | -$40.9M |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | -$6.9M | -$28.0M | -$28.6M | -$9.8M | -$14.1M | -$18.1M | -$14.1M | -$8.8M | -$11.7M | -$40.9M |
| EPS | $-528.62 | $-1316.05 | $-1099.19 | $-324.78 | $-294.93 | $-184.51 | $-26.06 | $-7.28 | $-4.33 | $-1.85 |
| EPS (Diluted) | $-524.65 | $-1316.05 | $-1099.19 | $-324.78 | $-294.93 | $-184.51 | $-26.06 | $-7.28 | $-4.33 | $-1.85 |
| Shares Outstanding (Diluted) | $15320 | $21294 | $26040 | $30116 | $47910 | $98270 | $539886 | $1.2M | $2.7M | $22.0M |
Price
| Price | $2.29 |
| Market Cap | $134M |
| Exchange | NASDAQ |
| Country | US |
Related companies: CATX · ELMD · INFU · INGN · NNOX · OM · PROF
Explore sector: Financial Services · Asset Management
More sections of HSDT: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks